pubmed-article:18439620 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0027061 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0178719 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0022023 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0037473 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0520863 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0073633 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0521116 | lld:lifeskim |
pubmed-article:18439620 | lifeskim:mentions | umls-concept:C0205087 | lld:lifeskim |
pubmed-article:18439620 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:18439620 | pubmed:dateCreated | 2008-6-27 | lld:pubmed |
pubmed-article:18439620 | pubmed:abstractText | The goal of this study was to test the hypothesis that the novel anti-ischemic drug ranolazine, which is known to inhibit late I(Na), could reduce intracellular [Na(+)](i) and diastolic [Ca(2+)](i) overload and improve diastolic function. Contractile dysfunction in human heart failure (HF) is associated with increased [Na(+)](i) and elevated diastolic [Ca(2+)](i). Increased Na(+) influx through voltage-gated Na(+) channels (late I(Na)) has been suggested to contribute to elevated [Na(+)](i) in HF. In isometrically contracting ventricular muscle strips from end-stage failing human hearts, ranolazine (10 micromol/L) did not exert negative inotropic effects on twitch force amplitude. However, ranolazine significantly reduced frequency-dependent increase in diastolic tension (i.e., diastolic dysfunction) by approximately 30% without significantly affecting sarcoplasmic reticulum (SR) Ca(2+) loading. To investigate the mechanism of action of this beneficial effect of ranolazine on diastolic tension, Anemonia sulcata toxin II (ATX-II, 40 nmol/L) was used to increase intracellular Na(+) loading in ventricular rabbit myocytes. ATX-II caused a significant rise in [Na(+)](i) typically seen in heart failure via increased late I(Na). In parallel, ATX-II significantly increased diastolic [Ca(2+)](i). In the presence of ranolazine the increases in late I(Na), as well as [Na(+)](i) and diastolic [Ca(2+)](i) were significantly blunted at all stimulation rates without significantly decreasing Ca(2+) transient amplitudes or SR Ca(2+) content. In summary, ranolazine reduced the frequency-dependent increase in diastolic tension without having negative inotropic effects on contractility of muscles from end-stage failing human hearts. Moreover, in rabbit myocytes the increases in late I(Na), [Na(+)](i) and [Ca(2+)](i) caused by ATX-II, were significantly blunted by ranolazine. These results suggest that ranolazine may be of therapeutic benefit in conditions of diastolic dysfunction due to elevated [Na(+)](i) and diastolic [Ca(2+)](i). | lld:pubmed |
pubmed-article:18439620 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:language | eng | lld:pubmed |
pubmed-article:18439620 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18439620 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18439620 | pubmed:month | Jul | lld:pubmed |
pubmed-article:18439620 | pubmed:issn | 1095-8584 | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:HasenfussGerd... | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:BelardinelliL... | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:MaierLars SLS | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:SchöndubeFrie... | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:TenderichGero... | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:WagnerStefanS | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:TirilomisTheo... | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:SossallaSamue... | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:RasenackEva... | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:RuffHannaH | lld:pubmed |
pubmed-article:18439620 | pubmed:author | pubmed-author:WeberSarah... | lld:pubmed |
pubmed-article:18439620 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18439620 | pubmed:volume | 45 | lld:pubmed |
pubmed-article:18439620 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18439620 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18439620 | pubmed:pagination | 32-43 | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:meshHeading | pubmed-meshheading:18439620... | lld:pubmed |
pubmed-article:18439620 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18439620 | pubmed:articleTitle | Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation. | lld:pubmed |
pubmed-article:18439620 | pubmed:affiliation | Heart Center, Georg-August-University Göttingen, Germany. | lld:pubmed |
pubmed-article:18439620 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18439620 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18439620 | lld:pubmed |